Precision Dose Inc. has recalled 801 cases of Carbamazepine Oral Suspension USP (100 mg/5 mL) because the medication was found to be subpotent, meaning it contains less active ingredient than required. This prescription medication, used primarily for treating seizures and certain types of nerve pain, was distributed in 5 mL unit dose cups across the United States. If you or a family member use this medication, check your supply immediately to see if it is part of the affected lot to ensure you are receiving the correct dosage for your condition.
Subpotent medication may not provide the intended therapeutic effect, which could lead to breakthrough seizures or a return of symptoms in patients being treated for epilepsy or chronic pain. No injuries or adverse events have been reported in the provided data.
Pharmacy refund and healthcare consultation
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.